Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-23-002179

President and CEO sold 5,029 shares at $28.73 ($144,483)

  • President and CEO acquired 82,240 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Watts Ryan J. President and CEO 2023-01-03 Grant or award +82,240 231,934 D: show line 1 in the form
Watts Ryan J. President and CEO 2023-01-04 Sale −5,029 $28.73 $144,483 2,213,464 I: show line 2 in the form
Open-market sales · 5,029 sh · avg $28.73 · $144,483

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Watts Ryan J. President and CEO 2023-01-03 Grant or award · Stock Option (right to buy) +246,720 246,720 D: show line 3 in the form
Loading xslF345X03/doc4.xml…